A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors

Several mechanisms have been described to elucidate the emergence of resistance to MAPK inhibitors in melanoma and there is a crucial need for biomarkers to identify patients who are likely to achieve a better and long-lasting response to BRAF inhibitors therapy. In this study, we developed a target...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Louveau, Baptiste, Delyon, Julie, De Moura, Coralie Reger, Battistella, Maxime, Jouenne, Fanelie, Golmard, Lisa, Sadoux, Aurelie, Podgorniak, Marie-Pierre, Chami, Ichrak, Marco, Oren, Caramel, Julie, Dalle, Stephane, Feugeas, Jean-Paul, Dumaz, Nicolas, Lebbe, Celeste, Mourah, Samia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2019
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6422198/
https://ncbi.nlm.nih.gov/pubmed/30899440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26707
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia